Annual Reports in Medicinal Chemistry, Volume 41

1st Edition

Serial Editors: Anthony Wood
Paperback ISBN: 9780120405411
eBook ISBN: 9780080467412
Imprint: Academic Press
Published Date: 8th December 2006
Page Count: 556
161.00 + applicable tax
137.00 + applicable tax
110.00 + applicable tax
185.00 + applicable tax
Compatible Not compatible
VitalSource PC, Mac, iPhone & iPad Amazon Kindle eReader
ePub & PDF Apple & PC desktop. Mobile devices (Apple & Android) Amazon Kindle eReader
Mobi Amazon Kindle eReader Anything else

Institutional Access

Table of Contents



Novel Approaches for the Treatment of Schizophrenia

1 Introduction

2 Approaches targeting altered NMDA receptor function

3 Approaches primarily targeting cognition

4 Approaches primarily targeting psychosis

5 Emerging mechanisms and conclusions

Recent Strategies for the Development of New Antidepressant Drugs

1 Introduction

2 Monoamine reuptake inhibitors

3 SSRIs with monoaminergic receptor modulation

4 Serotonergic receptor modulation

5 Neuropeptide receptor modulation

6 Conclusion

Neuroprotective Agents for the Treatment of Ischemic and Hemorrhagic Stroke

1 Introduction

2 Conclusion

Novel Sodium Channel Blockers for the Treatment of Neuropathic Pain

1 Introduction

2 Background

3 Biological target validation

4 Discovery of novel small molecule blockers

5 Conclusions

Centrally Acting Anti-Obesity Agents

1 Introduction

2 CB1R Antagonists

3 Neuropeptide receptor modulators

4 Aminergic receptor modulators

5 Monoamine re-uptake inhibitors

6 Conclusions

Nuclear Hormone Receptor Modulators for the Treatment of Diabetes and Dyslipidemia

1 Introduction


3 RXR modulators



6 Conclusion

11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors

1 Introduction

2 11β-HSD Isozymes

3 Potential therapeutic indications

4 11β-HSD1 Inhibitors

5 Conclusion

Glucokinase Activators for the Treatment of Type 2 Diabetes

1 Introduction

2 Biology of glucokinase

3 Small-molecule glucokinase activators

4 Conclusion and outlook

Renin Inhibitors

1 Introduction

2 Biology

3 Classical renin inhibitors

4 Aliskiren

5 Piperidines

6 Pi


Annual Reports in Medicinal Chemistry provides timely and critical reviews of important topics in medicinal chemistry together with an emphasis on emerging topics in the biological sciences, which are expected to provide the basis for entirely new future therapies. Sections I-IV are disease orientated and generally report on specific medicinal agents. Sections V and VI continue to emphasize important topics in medicinal chemistry, biology, and drug design. Section VII looks at Trends and Perspectives in the pharmaceuticals market.

Key Features

  • Critical reviews of the previous year's literature in many topics of interest to medicinal chemists
  • Highlights major developments in medicinal chemistry
  • Includes a comprehensive set of cumulative indices to easily locate topics in all published volumes


For medicinal, pharmaceutical and organic chemists


No. of pages:
© Academic Press 2006
Academic Press
eBook ISBN:
Paperback ISBN:

About the Serial Editors

Anthony Wood Serial Editor

Affiliations and Expertise

Pfizer Global Research and Development, Sandwich Laboratories, Sandwich, Kent, UK